Form 4 for PGNY Progyny, Inc.
Accepted 2023-12-18 00:00:00 ET · period of report 2023-12-14 · accession 0001551306-23-000116 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-12-18 | 2023-12-14 | PGNY | Schlanger David J | Executive COB, Dir | M - OptEx | $3.95 | +1,063 | 89.5K | +1% | +$4,199 |
| D | 2023-12-18 | 2023-12-14 | PGNY | Schlanger David J | Executive COB, Dir | S - Sale+OE | $37.53 | -1,063 | 88.4K | -1% | -$39.9K |
| D | 2023-12-18 | 2023-12-14 | PGNY | Schlanger David J | Executive COB, Dir | M - OptEx | $0.00 | -1,063 | 1.87M | -0.1% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-12-14 | M | A | 1,063 | $3.95 | 89,502 | D | — | — | (F1) Due to a clerical error in the initial report of this option grant, the conversion price is being updated to reflect the true and accurate conversion price on the date of grant. This error was recently discovered as this is the first exercise of options under this grant for the Reporting Person. |
| 2 | Common | Common Stock | 2023-12-14 | S | D | 1,063 | $37.53 | 88,439 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.50 to $37.70, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 3 | Derivative | Stock Option (Right to Buy) | 2023-12-14 | M | D | 1,063 | $0.00 | 1,868,959 | D | $3.95 · — to 2029-05-23 | 1,063 Common Stock | (F4) These options are fully vested and exercisable. |